These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15715001)

  • 1. [Bucillamine-induced dermatomyositis-like clinical features in a patient with rheumatoid arthritis].
    Takeda T; Shimizu Y; Takeuchi M; Hashimoto S; Nagai C; Uchiyama S; Iwata M
    Rinsho Shinkeigaku; 2005 Jan; 45(1):45-8. PubMed ID: 15715001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
    Matsuno H; Kitano T; Matsushita I; Tsuji H; Ochiai H
    Drugs Exp Clin Res; 1993; 19(5):205-11. PubMed ID: 8174492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of rheumatoid arthritis with bucillamine-induced myasthenia gravis treated by immunoadsorption therapy].
    Sawa N; Ubara Y; Hara S; Hideyuki K; Tagami T; Yokoyama K; Takemoto F; Yamada A; Mori T; Mikami A; Tachibana S; Nakase K
    Ryumachi; 1999 Feb; 39(1):33-8. PubMed ID: 10332215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment].
    Negishi M; Yamazaki J; Hosaka M; Iwabuchi H; Matsuda A; Kanemitsu H; Hiramatsu K; Kaga S; Hashimoto M; Kasama T
    Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential influences of bucillamine and methotrexate on the generation of fibroblast-like cells from bone marrow CD34+ cells of rheumatoid arthritis patients.
    Hirohata S; Yanagida T; Tomita T; Yoshikawa H
    Int Immunopharmacol; 2009 Jan; 9(1):86-90. PubMed ID: 19000788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine].
    Matsushima H; Takayanagi N; Sakamoto T; Motegi M; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M; Kawabata Y
    Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):55-9. PubMed ID: 11296388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis].
    Kishimoto N; Fujii K
    Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):321-5. PubMed ID: 12096503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of bucillamine-induced pneumonitis].
    Tanaka H; Nakahara K; Goto K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Apr; 30(4):695-701. PubMed ID: 1405091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of bucillamine-induced interstitial pneumonia].
    Hara A; Sakamoto O; Matsumoto M; Sakata T; Kohrogi H; Sugimoto M; Ando M; Araki S; Iwakiri T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1743-8. PubMed ID: 1447852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of rheumatoid arthritis complicated with a pneumonitis during concomitant treatment with methotrexate and bucillamine].
    Miwa Y; Kaga S; Hanaoka R; Shiozawa F; Hanyuda M; Kasama T; Negishi M; Ide H
    Ryumachi; 2002 Feb; 42(1):70-5. PubMed ID: 11925909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
    Obayashi M; Uzu T; Harada T; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung injury associated with bucillamine therapy].
    Negishi M; Kaga S; Kasama T; Hashimoto M; Fukushima T; Yamagata N; Tabata M; Kobayashi K; Ide H; Takahashi T
    Ryumachi; 1992 Apr; 32(2):135-9. PubMed ID: 1595005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical effects of bucillamine between additive combination and single administration study in rheumatoid arthritis.
    Nobunaga M; Yasuda M
    Agents Actions Suppl; 1993; 44():105-9. PubMed ID: 8372720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spontaneous remission of dermatomyositis which developed one month after normal delivery].
    Suwa A; Hirakata M; Tsuzaka K; Hama N; Fujii T; Mimori T; Akizuki M
    Ryumachi; 1992 Feb; 32(1):73-9. PubMed ID: 1604420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of rheumatoid arthritis developed after polymyositis].
    Miyoshi T; Yoshinaga Y; Ota Y
    Ryumachi; 2003 Jun; 43(3):583-90. PubMed ID: 12910969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy].
    Kikuchi M; Saeki T; Ito S; In H; Saito T; Ueno M; Sato T; Suzuki S; Nakano M; Ozawa T
    Ryumachi; 1993 Jun; 33(3):215-22. PubMed ID: 8346463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre trial of bucillamine in the treatment of early rheumatoid arthritis (SNOW study).
    Sagawa A; Fujisaku A; Ohnishi K; Mukai M; Yasuda I; Amasaki Y; Shimizu M; Ichikawa K; Ohsaki H
    Mod Rheumatol; 2011 Jun; 21(3):251-7. PubMed ID: 21188453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Yellow nail syndrome" and rheumatoid arthritis.
    Ichikawa Y; Shimizu H; Arimori S
    Tokai J Exp Clin Med; 1991 Dec; 16(5-6):203-9. PubMed ID: 1820660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.